Market Place
Sourcing Support
All News #Library
Others
CAMP4 Therapeutics Announces Nasdaq Inducement Grants
17 Apr 2026 //
GLOBENEWSWIRE
CAMP4 Appoints Michael Maclean To Its Board Of Directors
24 Mar 2026 //
GLOBENEWSWIRE
CAMP4 Announces Inducement Grant Under Nasdaq LR 5635(c)(4)
16 Jan 2026 //
GLOBENEWSWIRE
CAMP4 To Present At J.P. Morgan Healthcare Conference
06 Jan 2026 //
GLOBENEWSWIRE
CAMP4 Therapeutics Reveals Inducement Grant Per Nasdaq LR
14 Nov 2025 //
GLOBENEWSWIRE
CAMP4 Raises $100M for First-in-Class SYNGAP1 Disorder Treatment
10 Sep 2025 //
GLOBENEWSWIRE
CAMP4 Reports Q2 2025 Financials and Corporate Highlights
14 Aug 2025 //
GLOBENEWSWIRE
CAMP4 Presents Data on SYNGAP1 and Urea Disorders at ASGCT
16 May 2025 //
GLOBENEWSWIRE
CAMP4 Reports Q1 2025 Financial Results and Highlights
13 May 2025 //
GLOBENEWSWIRE
CAMP4 Appoints Industry Veterans to Board
18 Mar 2025 //
GLOBENEWSWIRE
CAMP4 To Present At 43rd Annual J.P. Morgan Healthcare Conference
13 Jan 2025 //
GLOBENEWSWIRE
CAMP4 Reports Third Quarter 2024 Financial Results
21 Nov 2024 //
GLOBENEWSWIRE
Upstream swells IPO to $255M as it lists alongside CAMP4
11 Oct 2024 //
FIERCE BIOTECH
Kaiser Permanente-backed biopharma CAMP4 files for US IPO
21 Sep 2024 //
REUTERS
CAMP4’s funding influx paves the way for tapping regulatory RNA
29 Jul 2022 //
PHARMACEUTICAL-TECHNOLOGY
Equipped with $100M in new cash, CAMP4 takes trail to the clinic
19 Jul 2022 //
FIERCEBIOTECH
CAMP4 Tx Appoints Veteran Drug Developer Ann Barbier, M.D., Ph.D. as CMO
14 Mar 2022 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.